Skip Nav Destination
Issues
Cancer Research
Table of Contents
Reviews
Classification of Proliferative Pulmonary Lesions of the Mouse: Recommendations of the Mouse Models of Human Cancers Consortium
Alexander Yu. Nikitin; Ana Alcaraz; Miriam R. Anver; Roderick T. Bronson; Robert D. Cardiff; Darlene Dixon; Armando E. Fraire; Edward W. Gabrielson; William T. Gunning; Diana C. Haines; Matthew H. Kaufman; R. Ilona Linnoila; Robert R. Maronpot; Alan S. Rabson; Robert L. Reddick; Sabine Rehm; Nora Rozengurt; Hildegard M. Schuller; Elena N. Shmidt; William D. Travis; Jerrold M. Ward; Tyler Jacks
Advances in Brief
Molecular Biology, Pathobiology, and Genetics
p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis
S. Perwez Hussain; Paul Amstad; Peijun He; Ana Robles; Shawn Lupold; Ichiro Kaneko; Masato Ichimiya; Sagar Sengupta; Leah Mechanic; Shu Okamura; Lorne J. Hofseth; Matthew Moake; Makoto Nagashima; Kathleen S. Forrester; Curtis C. Harris
Gene Expression Profile of Gastric Carcinoma: Identification of Genes and Tags Potentially Involved in Invasion, Metastasis, and Carcinogenesis by Serial Analysis of Gene Expression
Naohide Oue; Yoichi Hamai; Yoshitsugu Mitani; Shunji Matsumura; Yasuhiro Oshimo; Phyu Phyu Aung; Kazuya Kuraoka; Hirofumi Nakayama; Wataru Yasui
Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma
Yoshitaka Hippo; Kiyotaka Watanabe; Akira Watanabe; Yutaka Midorikawa; Shogo Yamamoto; Sigeo Ihara; Susumu Tokita; Hiroko Iwanari; Yukio Ito; Kiyotaka Nakano; Jun-ichi Nezu; Hiroyuki Tsunoda; Takeshi Yoshino; Iwao Ohizumi; Masayuki Tsuchiya; Shin Ohnishi; Masatoshi Makuuchi; Takao Hamakubo; Tatsuhiko Kodama; Hiroyuki Aburatani
Epigenetic Profiling in Chronic Lymphocytic Leukemia Reveals Novel Methylation Targets
Laura J. Rush; Aparna Raval; Pauline Funchain; Amy J. Johnson; Lisa Smith; David M. Lucas; Melania Bembea; Te-Hui Liu; Nyla A. Heerema; Laura Rassenti; Sandya Liyanarachchi; Ramana Davuluri; John C. Byrd; Christoph Plass
Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning
Yuriko Mori; Jing Yin; Fumiaki Sato; Anca Sterian; Lisa A. Simms; Florin M. Selaru; Karsten Schulmann; Yan Xu; Andreea Olaru; Suna Wang; Elena Deacu; John M. Abraham; Joanne Young; Barbara A. Leggett; Stephen J. Meltzer
Cell and Tumor Biology
Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo
Nicole Concin; Kirsten Becker; Neda Slade; Susan Erster; Elizabeth Mueller-Holzner; Hanno Ulmer; Guenter Daxenbichler; Alain Zeimet; Robert Zeillinger; Christian Marth; Ute M. Moll
The tyrp1-Tag/tyrp1-FGFR1-DN Bigenic Mouse: A Model for Selective Inhibition of Tumor Development, Angiogenesis, and Invasion into the Neural Tissue by Blockade of Fibroblast Growth Factor Receptor Activity
Benoı̂t Rousseau; Frédéric Larrieu-Lahargue; Sophie Javerzat; Frédéric Guilhem-Ducléon; Friedrich Beermann; Andreas Bikfalvi
Stromal Cell-Derived Factor-1α Promotes Melanoma Cell Invasion across Basement Membranes Involving Stimulation of Membrane-Type 1 Matrix Metalloproteinase and Rho GTPase Activities
Rubén A. Bartolomé; Beatriz G. Gálvez; Natividad Longo; Françoise Baleux; Goos N. P. van Muijen; Paloma Sánchez-Mateos; Alicia G. Arroyo; Joaquin Teixidó
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Topical Treatment with Inhibitors of the Phosphatidylinositol 3′-Kinase/Akt and Raf/Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathways Reduces Melanoma Development in Severe Combined Immunodeficient Mice
Barbara Bedogni; Melony S. O’Neill; Scott M. Welford; Donna M. Bouley; Amato J. Giaccia; Nicholas C. Denko; Marianne Broome Powell
Calmodulin-Dependent Cyclic Nucleotide Phosphodiesterase (PDE1) Is a Pharmacological Target of Differentiation-Inducing Factor-1, an Antitumor Agent Isolated from Dictyostelium
Kasumi Shimizu; Taku Murata; Toshiro Tagawa; Katsunori Takahashi; Ryoki Ishikawa; Yumiko Abe; Kohei Hosaka; Yuzuru Kubohara
Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging
Ryuta Saito; John R. Bringas; Tracy R. McKnight; Michael F. Wendland; Christoph Mamot; Daryl C. Drummond; Dmitri B. Kirpotin; John W. Park; Mitchel S. Berger; Krys S. Bankiewicz
Cotreatment with Histone Deacetylase Inhibitor LAQ824 Enhances Apo-2L/Tumor Necrosis Factor-Related Apoptosis Inducing Ligand-Induced Death Inducing Signaling Complex Activity and Apoptosis of Human Acute Leukemia Cells
Fei Guo; Celia Sigua; Jianguo Tao; Purva Bali; Prince George; Yunqing Li; Sylvie Wittmann; Lynn Moscinski; Peter Atadja; Kapil Bhalla
Immunology
Human CTLs to Wild-Type and Enhanced Epitopes of a Novel Prostate and Breast Tumor-Associated Protein, TARP, Lyse Human Breast Cancer Cells
SangKon Oh; Masaki Terabe; C. David Pendleton; Anu Bhattacharyya; Tapan K. Bera; Malka Epel; Yoram Reiter; John Phillips; W. Marston Linehan; Claude Kasten-Sportes; Ira Pastan; Jay A. Berzofsky
Endocrinology
Epidemiology
Letters to the Editor
Corrections
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds